Administration Core

行政核心

基本信息

  • 批准号:
    10452578
  • 负责人:
  • 金额:
    $ 11.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-03-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT - Administration Core (Core A) In this renewal application, we propose the basic and applied research needed to advance an entirely new concept for the non-invasive surgical management of kidney stones. During the next funding period, we will develop and deliver a multifunctional integrated ultrasound-based therapy system that images, breaks, detaches and expels stones. This will be a significant undertaking. The research will be performed at five institutions and involve a team of over 50 researchers, staff, consultants, and advisors. The overall research strategy is complex. The numerous synergistic interactions among the Projects and Cores will require careful coordination. For these reasons a robust Administration Core is essential to the success of the Program. We are in Year-24 of this PPG. Over this time, we have enjoyed remarkable stability among the participating institutions and our key personnel. The current proposal includes two Projects (Projects 1 & 2) at the Applied Physics Laboratory (APL)-University of Washington (UW) with subcontracts/sub-budgets to CalTech, and the UW Departments of Urology and Mechanical Engineering. A third Project (Project 3) is at Indiana University (IU) with subcontracts to IU-Health, Oxford University, and the University of Illinois. The Administration Core (Core A) and the Engineering Core (Core C) will be at the APL-UW, while the Statistical Core (Core B) will be at IU. We have a Board of Directors to oversee clinical impact, an External Advisory Board to assure rigor and reproducibility, a Data Safety Monitor Board for safety review of clinical trials, and a study monitor to assure regulatory compliance. In our experience the main challenge seen in administering a multi-institutional Program such as ours is in keeping the individual teams on track, working continually toward completion of shared goals and objectives. We have had tremendous success at this. The key to what we have been able to accomplish distills down to several essential elements. Our investigators are skilled at collaborative science, we work extremely well together, as individuals we are dedicated to the overall success of the group, and we build by keeping communication at a very high level. This is successful team science facilitated by strong executive leadership. Specifically, Core A provides fiscal, scientific, and regulatory leadership for the Program Project as follows: ● Aim 1. Provide fiscal stewardship; ● Aim 2. Facilitate scientific progress and productivity; ● Aim 3. Promote and monitor synergistic collaboration among the Projects and enable productive utilization of Core resources; ● Aim 4. Liaise with PPG advisors, safety and study monitors, and the NIDDK; ● Aim 5. Maintain regulatory approval and compliance.
项目概要/摘要-管理核心(核心A) 在这一更新申请中,我们提出了推进一个全新的 肾结石的治疗方法有哪些?在下一个财政年度,我们将 开发并提供一种多功能集成的基于超声的治疗系统, 分离并排出结石。这将是一项重要的工作。研究将在五点进行 该研究所是一个由50多名研究人员、工作人员、顾问和顾问组成的团队。整体研究 战略是复杂的。项目和核心之间的许多协同作用需要仔细考虑, 协同由于这些原因,一个强大的管理核心是必不可少的计划的成功。 我们在这个PPG的第24年。在这段时间里,我们在国际社会中享有显著的稳定, 参与机构和我们的主要人员。目前的建议包括两个项目(项目1和2), 应用物理实验室(APL)-华盛顿大学(UW), 加州理工学院,以及华盛顿大学泌尿系和机械工程系。第三个项目(项目3)在 印第安纳州大学(IU)与IU健康,牛津大学和伊利诺伊大学分包合同。的 行政核心(核心A)和工程核心(核心C)将在APL-UW,而统计核心(核心C)将在APL-UW。 核心(核心B)将为IU。我们有一个董事会来监督临床影响,一个外部顾问 委员会,以确保严格性和可重复性,数据安全监测委员会的安全审查的临床试验,和 研究监查以确保法规遵从性。 根据我们的经验,在管理像我们这样的多机构项目时, 使各个团队保持在正确的轨道上,不断努力完成共同的目标和目的。 我们在这方面取得了巨大的成功。我们所取得的成就的关键在于 几个基本要素。我们的研究人员擅长合作科学,我们工作得非常好。 作为个人,我们共同致力于集团的整体成功,我们通过保持 沟通在一个非常高的水平。这是由强有力的行政领导推动的成功的团队科学。 具体而言,核心A为计划项目提供以下财政、科学和监管领导: ·目标1。提供财政管理; ·目标2。促进科学进步和生产力; ●目标3。促进和监测项目之间的协同合作, 利用核心资源; ·目标4。与PPG顾问、安全性和研究监查员以及NIDDK联络; ·目标5。保持监管批准和合规性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL R BAILEY其他文献

MICHAEL R BAILEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL R BAILEY', 18)}}的其他基金

Noninvasive, non-ionizing localization and clearance of kidney stones
无创、非电离定位和清除肾结石
  • 批准号:
    8284330
  • 财政年份:
    2011
  • 资助金额:
    $ 11.5万
  • 项目类别:
Noninvasive, non-ionizing localization and clearance of kidney stones
无创、非电离定位和清除肾结石
  • 批准号:
    8585634
  • 财政年份:
    2011
  • 资助金额:
    $ 11.5万
  • 项目类别:
Noninvasive, non-ionizing localization and clearance of kidney stones
无创、非电离定位和清除肾结石
  • 批准号:
    8153391
  • 财政年份:
    2011
  • 资助金额:
    $ 11.5万
  • 项目类别:
Noninvasive, non-ionizing localization and clearance of kidney stones
无创、非电离定位和清除肾结石
  • 批准号:
    8460915
  • 财政年份:
    2011
  • 资助金额:
    $ 11.5万
  • 项目类别:
Physical Mechanisms of Hemostasis by Intense Ultrasound
强超声止血的物理机制
  • 批准号:
    6845401
  • 财政年份:
    2002
  • 资助金额:
    $ 11.5万
  • 项目类别:
Physical Mechanisms of Hemostasis by Intense Ultrasound
强超声止血的物理机制
  • 批准号:
    6687273
  • 财政年份:
    2002
  • 资助金额:
    $ 11.5万
  • 项目类别:
Interactive Effects of Combined Imaging, BWL, and Ultrasonic Propulsion
组合成像、BWL 和超声波推进的交互效果
  • 批准号:
    10192511
  • 财政年份:
    1997
  • 资助金额:
    $ 11.5万
  • 项目类别:
In-Office, Ultrasound-Based Breakage and Removal of Urinary stones
办公室内超声破碎和去除尿路结石
  • 批准号:
    10452577
  • 财政年份:
    1997
  • 资助金额:
    $ 11.5万
  • 项目类别:
Interactive Effects of Combined Imaging, BWL, and Ultrasonic Propulsion
组合成像、BWL 和超声波推进的交互效果
  • 批准号:
    10452581
  • 财政年份:
    1997
  • 资助金额:
    $ 11.5万
  • 项目类别:
Engineering Core C
工程核心C
  • 批准号:
    10681342
  • 财政年份:
    1997
  • 资助金额:
    $ 11.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了